Drug Profile
Flurbiprofen transdermal
Alternative Names: Transact LAT transdermal system; TransAct-LATLatest Information Update: 12 Jan 2022
Price :
$50
*
At a glance
- Originator Amdipharm
- Class Antipyretics; Antirheumatics; Nonsteroidal anti-inflammatories; Propionic acids
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Musculoskeletal pain
Most Recent Events
- 21 Oct 2015 Amdipharm has been acquired by Concordia Healthcare corp